v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Operating Activities:    
Net income $ 388,814 $ 266,607
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and impairments 84,408 70,518
Debt placement fee amortization expense 1,201 1,080
Loss on sale and retirement of assets 3,310 2,298
Earnings of non-controlled entities (2,421) (2,787)
Distributions from investments in non-controlled entities 1,713 1,302
Equity-based incentive compensation expense 12,753 10,282
Changes in employee benefit plan assets and benefit obligations 1,762 982
Changes in operating assets and liabilities:    
Trade accounts receivable and other accounts receivable 25,486 8,167
Inventory (1,718) 13,984
Energy commodity derivatives contracts, net of derivatives deposits (4,133) (4,628)
Accounts payable 486 (322)
Accrued payroll and benefits (11,434) (4,429)
Accrued interest payable 1,038 (633)
Accrued taxes other than income (3,679) (2,737)
Accrued product purchases (25,278) (22,885)
Deferred revenue 6,174 7,815
Current and noncurrent environmental liabilities (3,820) (12,850)
Other current and noncurrent assets and liabilities 2,694 7,909
Net cash provided by operating activities 477,356 339,673
Investing Activities:    
Additions to property, plant and equipment (149,138) (181,165)
Proceeds from sale and disposition of assets 107 2,305
Decrease in accounts payable related to capital expenditures (4,112) (30,044)
Investments in non-controlled entities (285,945) (99,667)
Distributions in excess of earnings of non-controlled entities 1,765 750
Net cash used by investing activities (437,323) (307,821)
Financing Activities:    
Distributions paid (271,914) (228,380)
Net commercial paper borrowings 220,977 0
Borrowings under long-term notes 257,713 0
Payments on notes (250,000) 0
Debt placement costs (2,887) 0
Net payment on financial derivatives (3,613) 0
Settlement of tax withholdings on long-term incentive compensation (14,813) (12,259)
Net cash used by financing activities (64,537) (240,639)
Change in cash and cash equivalents (24,504) (208,787)
Cash and cash equivalents at beginning of period 25,235 328,278
Cash and cash equivalents at end of period 731 119,491
Supplemental non-cash investing and financing activities:    
Issuance of limited partner units in settlement of equity-based incentive plan awards $ 7,315 $ 6,404